Recap: 2021 SCRS Site Solutions Summit and Looking Ahead to 2022

The clinical trial industry is still abuzz after the amazing 2021 SCRS Site Solutions Summit in Hollywood, Florida. From the informative workshops and collaborative exhibit hall discussions to the receptions, everyone walked away with an enlightened perspective to push the clinical trial space forward. The team at Devana Solutions has assembled some of its thoughts and highlights from one of the industry’s biggest events of the year.

Devana Solutions CEO and Co-founder, Barry Lake, participated in several workshops and panels. He kicked off a Friday afternoon session with a discussion on the future of decentralized, patient-centric clinical trials with Irfan Khan, CEO of Circuit Clinical,

Paul Evans, CEO of Velocity Clinical Research, Jeff Kingsley, CEO of IACT Health & COO of hyperCORE, and Kristen Andrews, Senior Director, Labcorp Drug Development.

From left to right: Irfan Khan, MD, Dr. Jeff Kingsley, Dr. G. Paul Evans, Barry Lake, and Kristin Andrews

“This workshop brought together some of the sharpest minds and most accomplished professionals in the clinical trial industry to form a powerful ‘think tank’ to kick off our first day, and we had perspectives from both the site and Sponsor/CRO sides,” said Lake.

From left to right: Irfan Khan, MD, Kristin Andrews, Dr. Jeff Kingsley, Dr. G. Paul Evans

SCRS’ Site Solutions Summit is all about advancing the clinical trial industry forward, including advancements in purpose-built technology, such as Devana Solutions.

One technology-related panel discussion, of which Lake participated, also included RealTime CTMS’ CEO, Rick Greenfield. RealTime CTMS and Devana Solutions have a current API-integration, providing a multitude of benefits to their mutual clients. Lake and Greenfield both emphasized that “interoperability” of tech systems is fundamental to site success and ultimately, sponsor and CRO success.

“Technology, like what Devana Solutions offers, must meet the needs of all parties involved, from sites and CROs to sponsors,” Lake said. As this industry evolves, “there may never be a common platform utilized by the entire industry.”

While the workshops and panels offered incredible insight into where the clinical trial industry is headed, it was the open dialogue between all industry stakeholders that really laid the foundation for success.   

Devana Solutions’ Vice President of Operations, Linda Parks, met with several of our partners and acknowledged that the dialogue helps lead a mutual learning process. “Each conversation reveals more, and what we take away from SCRS’ Site Solutions Summit is invaluable. We enjoyed hearing from colleagues about the specific technology pain points that are preventing them from making data-backed end-to-end decisions to their clinical trial operations,” said Parks.

From left to right: Emily Wike, Lorraine Da Mata

Director of Strategic Partnerships, Emily Wike, optimistically saw conference attendees step back and view their processes from a higher altitude. “The interest in Devana grows more with each conference. For those that just learned about Devana, their eyes were opened to a whole new way to manage their clinical trials,” said Wike.

While our out-of-the-box solutions are certainly beneficial, it’s Devana Solutions’ unique ability to customize its technology to each research organization’s specific needs and processes that is pivotal. “No research organization wants to be constrained during the study startup process, and they certainly shouldn’t be constrained by a technology forcing major process change,” said Shenefield.  “One-by-one, people who stopped by our booth were amazed at the level of customization that we provide as a partner, to unlock those key insights that shape better clinical trial business decisions,” said Shenefield. 

Above: Roxanne Shenefield

At this year’s SCRS Site Solutions Summit, while our main focus was to bring about a positive shift in the clinical trial space, being face to face and sharing an occasional fist bump or handshake, was an overdue and welcomed experience.

If you stopped by our booth, you may have enjoyed a few of the fun activities we hosted, like meeting Devana, the Huntress, live and in the flesh.  

From left to right: Linda Parks, Lorraine Da Mata, Devana, Emily Wike, Roxanne Shenefield

Devana had quite a few friends stop to take photos with her, including Aspen Insights, LLC and Optimed Research

Pictured with Devana from left to right; Brianna McKernon and Kate Collins
Pictured with Devana from left to right; Annie Schertzer and Damea Alexander

Others stopped by our booth for a chance to win a Starbucks gift card through an archery contest; hit the bullseye and win! Devana Solutions helps research organizations stay on target, after all, and we witnessed some pretty decent marksmen.

Longtime friend of Devana Solutions and client-partner, Craig Koch of Velocity Clinical, took dead aim and nailed the bullseye.

Those who were new to the innovative Devana Solutions technology scheduled a demo at the booth. Wike summed up the reaction from demo participants, “I was told by many, after viewing a demo, that we caused them to rethink their current processes. The most common customer need discussed was around growing research organizations; they are simply too busy and growing too quickly to be able to manage their clinical trials in spreadsheets or other systems that are not clinical trials industry-specific. They were relieved to know that Devana existed as a solution.” 

Once the demos and exhibit hall fun came to an end, attendees migrated to the awards ceremony and dinner on Saturday night.

Devana Solutions would like to congratulate both Pfizer and PPD as the SCRS Eagle Award recipients as Sponsor and CRO of Choice, respectively, as well as the Christine K. Pierre Site Impact Award recipient, Michele Cameron, Director of Clinical Research, Clearwater Cardiovascular Consultants. We would also like to recognize industry veteran and HCA Healthcare’s VP of Research and Compliance, David Vulcano, and the contributions he has made to the clinical trial industry thus far and are excited to see the mark he makes as the new Honorary President of the Society for Clinical Research Sites.

Will we see you at the 2022 SCRS Site Solutions Summit? With plans already underway, next year’s Summit is to take place October 7th through 9th, with Site Symposiums starting on October 6th. We are already making our plans and we can’t wait to see you, once again!

“There is so much to benefit from attending the SCRS Site Solutions Summit, spending quality time and exchanging insights with our industry partners. Our team is already discussing how to make the 2022 Summit even better than the last,” said Lake.

But don’t wait until 2022 to talk to us!  and discuss your clinical trial data management pain points now. Let’s find a solution today!  Please reach out to us using the contact form below.

2021 SCRS Site Solutions Summit: Clinical Trial Data Management Success

The 2021 SCRS Site Solutions Summit is finally here! If you’re like our team, you’re probably packing up and heading to the Diplomat Beach Resort in Hollywood, Florida, for a great weekend of learning and networking to enhance your clinical trial operations. During most clinical research conferences, one of the most frequently discussed topics is data management. Many research organizations discover that they lack the proper tools for complete data analysis. The team at Devana Solutions wants to ensure that having the knowledge and tools to produce precise data is a big part of your SCRS Site Solutions Summit experience.

The Key to Comprehensive Clinical Trial Data Management

Did you know that approximately 70% of data is lost during the clinical trial process? This creates tremendous blind spots for all clinical trial stakeholders. This lack of visibility means that clinical trial executives are losing out on the advantages to make more targeted business decisions. Devana Solutions developed an end-to-end technology solution to satisfy your clinical trial data needs, and spending just 15 minutes looking at the platform will open your mind to new ways to manage critical data to ensure your organization is on the right track.

Discussing Clinical Trial Data Management

Aside from a demo of the Devana Solutions platform, there are three data-centric events at the SCRS Site Solutions Summit we’d like to put on your radar.

We first want to alert you to Master Workshop III, Position Your Site to Lead the Charge to the Future of Decentralized, Patient-centric Clinical Trials. The event takes place Friday, October 1st at 2:00 PM:

Devana Solutions CEO and Co-Founder Barry Lake, will lead an interactive discussion on the rapid evolution, spurred by the pandemic, towards a more decentralized, patient-centric approach to designing and executing clinical trials.

Joining Barry will be:
Irfan Khan, CEO of Circuit Clinical
Paul Evans, CEO of Velocity Clinical Research
Jeff Kingsley, CEO of IACT Health & COO of hyperCORE
Kristen Andrews, Senior Director, Labcorp Drug Development

The second event we recommend adding to your calendar occurs Saturday, October 2nd at 1:30 PM. This event is Breakout Session I, What We Really Want: Site & Patient Input for Vendors with Respect to Technology.

Similar to a focus group, this Breakout Session will collaboratively collect perspectives from the field to help impress future technology adoption and advancement.
Devana Solutions CEO and Co-Founder Barry Lake, will serve as one of the panelists alongside Mary Costello, Head of Site & Investigator Network, Medable, Inc.
The event will be facilitated by Doug Schantz, VP, Clinical Operations, Alexion Pharmaceuticals.
The third event swings specifically back to clinical trial data management. Breakout Session II, Trust-Building: Utilizing Your Data to Validate Your Site takes place Saturday, October 2nd at 3:00 PM.

This session will help you understand the data sources that sponsors and CROs are using to further validate your site and provide perspective on what kinds of data you should track and share to position your site for selection.

Devana Solutions CEO and Co-Founder Barry Lake, will facilitate the panel.
He will be joined by Kerry Gorman of IQVIA and Jeff Stein of Stamford Therapeutics Consortium.

Gain Hands-On Control of Clinical Trial Data Management with a Devana Solutions Demo

While you will be engaged in discussion and taking notes at the above sessions, the best way to see your expanded use of data is to view a demo from a leading clinical trial data management platform, like Devana Solutions.

Navigating through the Devana Solutions’ platform, you’ll find customized workflow automation and data around, but not limited to, these critical areas:
Business development
Feasibility and site selection
Contract and budget negotiations
Startup activities and timelines
Indication performance history
Site and investigator capabilities

Devana Solutions unlocks key data and provides complete visibility into all aspects of the clinical trial process, giving your research organization a competitive edge.
During this 15-minute demo, the Devana Solutions team will walk through each step of our customization process to ensure that you are capturing the key metrics specific to your organization – before and after the trial.

Interested in scheduling a demo before you arrive at the Summit? Connect with our team here, and add a Devana demo to your “to-do” list. Need a guide to other must-attend events? We’ve put that list together for you. See you at the SCRS Global Site Solutions Summit!

2021 SCRS Site Solutions Summit: What to Expect

The excitement is building for the 2021 SCRS Global Site Solutions Summit.  The SCRS recently announced new speakers added to the lineup.  They include former Surgeon General Jerome Adams, MD, MPH, and Alex Azar, 24th Secretary of the U.S. Department of Health and Human Services. So how do you maximize your time at the Summit?  Whether you’re a newbie or a returning attendee, the Devana Solutions team has put together a list of what to expect at this year’s Summit.

Grow Your Industry Knowledge

One of the great benefits of attending the Summit is learning where the industry is headed.  There are many events throughout the Summit that take a look at the technology and relationships that drive the great research work.

Here are some of the events we are looking forward to:

Friday, October 1st at 2:00 PM: Master Workshop III, Position Your Site to Lead the Charge to the Future of Decentralized, Patient-centric Clinical Trials.

Devana Solutions CEO and Co-Founder, Barry Lake, joined by a distinguished panel of industry leaders, will lead an interactive discussion on the rapid evolution, spurred by the pandemic, towards a more decentralized, patient-centric approach to designing and executing clinical trials.   

“Site Solutions Summit has always attracted industry leaders and been solutions-oriented” says Lake, “Our Master Workshop on October 1st is no exception with Dr. G. Paul Evans, Irfan Khan, MD and Dr. Jeff Kingsley providing thought leadership from the site perspective with Kristin Andrews of Labcorp Drug Development, the sponsor/CRO viewpoint. Solutions to position your site to lead as trials become more decentralized will benefit all workshop attendees.”

Saturday, October 2nd at 1:30 PM: Breakout Session I, What We Really Want: Site & Patient Input for Vendors with Respect to Technology.

This interactive session focuses on technology’s role in the clinical trials industry.   Similar to a focus group, this Breakout Session will collaboratively collect perspectives from the field to help impress future technology adoption and advancement.  

Devana Solutions CEO and Co-Founder, Barry Lake  will serve as one of the panelists.

Lake says, “Too many technology vendors neglect the site and patient perspective when introducing new advances at the site-level. Since Devana Solutions was purpose-built by site professionals to meet leadership’s need for performance data transparency, I’m hopeful that my experience will resonate from the site and patient viewpoint.”

Saturday, October 2nd at 3:00 PM: Breakout Session II, Trust-Building: Utilizing Your Data to Validate Your Site.

Sponsors and CROs are seeking increased visibility into sites’ potential patient access. This session will help you understand the data sources that sponsors and CROs are using to further validate your site and provide perspective on what kinds of data you should track and share to position your site for selection.  

Devana Solutions CEO and Co-Founder, Barry Lake will facilitate the panel.  

“Devana Solutions has always been driven by our site-based roots to take the initiative and be accountable for accessing and analyzing their own performance metrics data so I’m excited to hear from Kerry Gorman of IQVIA, a leading CRO with a strong history of leveraging site performance data and since Stamford Therapeutics Consortium manages trials across all phases, Jeff Stein’s perspective from a leading site organization will mean a powerful panel,” says Lake.  

Expand Your Business and Meet New People

While you will grow your insights at the events of the Summit, you will also expand your business and connections in the field.  Whether it’s interacting with panelists or sharing thoughts with others in the breakout sessions, you will walk away with more industry relationships.  Many of these new connections can evolve into working partnerships.  We’ve had the pleasure of meeting new people and then serving their clinical trial data and analytics needs.

There may be no better place to build these relationships than the EXPO Hall.  This is the nerve center of the Summit, and this gives you a chance to interact with many of the teams in the industry.  You can spend hours walking the floors and meeting with the teams at their booths. The Devana Solutions team loves seeing familiar faces and meeting new people at the Site Solutions Summit.

We hope to see you at booth 512!   

We are offering qualified attendees the chance at a $250 gift card.  Every person who takes an on-site demo of our Devana Solutions clinical trial analytics platform will be entered for a random drawing of one gift card.  If you’d like to schedule a session with us before the Site Solutions Summit, use the contact form below and reach out to our team.

Have Fun

We love what we do, and we know you do too.  The outcome of our work brings the world to a better place, and while we take what we do seriously, we also like to enjoy ourselves.

We have a couple of events at our booth 512 that we know you will enjoy!

Since Devana Solutions platform is about helping your organization be more on target, we’ve incorporated a fun little game at the show.

We want to see how on target you are, and we are offering a $5 Starbucks gift card to anyone who hits a bullseye at our Devana Solutions archery station.

One other fun event we have is the opportunity to meet Devana!

In Slavic mythology, our namesake, Devana, translates to the Goddess of the Hunt, and Devana Solutions is committed to bringing you unmatched analytical visibility into your clinical trials to dial in your hunt to pinpointed targeting.

Devana, the huntress herself, will be attending the Opening Reception on Friday. We invite you to stop by booth 512 for a chance to meet Devana and grab a photo with her for your social accounts. After all, what better content to send back to the corporate office than a photo of you and the huntress?

Devana is a 2021 Site Solutions Summit Premiere and Experience Sponsor, and we are excited to meet with your team at the SCRS Global Site Solutions Summit. 

We’d love to show you what Devana Solutions can do for your clinical trial business decisions.  If you’d like to schedule an on-site demo with our team (and enter for a chance to win a $250 Amazon gift card), fill out your information below, and the Devana Solutions team will reach out to you prior to the Summit.  

    2021 Global Site Solutions Summit Must-Attend Events

    The clinical trials industry is buzzing with excitement as the countdown to the SCRS Global Site Solutions Summit commences. Taking place October 1st through 3rd, live and in-person, this year’s Summit is sure to be one for the books. The team at Devana Solutions, a 2021 Site Solutions Summit Premiere and Experience Sponsor have broken down some of this year’s must-attend events.  

    Global Site Solutions Summit 

    The Global Site Solutions Summit, otherwise known as “the site’s meeting”, is one of the industry’s most anticipated events. Bringing together sites, sponsors, CROs and innovative minds, the Summit has one sole purpose; to improve the clinical trial space and advance medicine together! This year’s event will be held at the spectacular Diplomat Beach Resort in Hollywood, Florida.  

    As you begin to fill your calendar, Devana Solutions has a look at some of the “can’t miss” workshops, sessions, and events on the agenda.  

    If you plan to arrive on the 30th, you will have access to the early registration and two Site Partnership Symposiums with Lilly and IQVIA. The official Summit kick-off is October 1st and attendees can look forward to a full day of workshops. One we highly recommend attending is the Master Workshop III at 2:00 PM: 

    Position Your Site to Lead the Charge to the Future of Decentralized, Patient-centric Clinical Trials 

    Devana Solutions CEO and Co-Founder, Barry Lake, joined by a distinguished panel of industry leaders from the site sector and a major global CRO, will lead an interactive discussion on the rapid evolution, spurred by the pandemic, towards a more decentralized, patient-centric approach to designing and executing clinical trials.   

    You will gain knowledge in these three key areas:  

    • Gain a better understanding of the rapid transition to more decentralized, patient-centric clinical trial solutions  
    • Understand the resulting impacts being felt at the site-level; such as the rapid adoption of telemedicine, devices, wearables, and innovative technology platforms, transforming clinical trial management which could have profound implications for sites  
    • Better position your site organization to embrace the change and thrive in a future decentralized clinical trial environment, ultimately for the benefit of the patients     

    Joining Barry will be:   

    Irfan Khan, CEO of Circuit Clinical  

    Paul Evans, CEO of Velocity Clinical Research  

    Jeff Kingsley, CEO of IACT Health & COO of hyperCORE  

    If you have never attended the SCRS Global Site Solutions Summit, you will want to make sure you attend the Opening and Welcome in the Great Hall with SCRS’ Allyson Small, Sean Soth, and Casey Orvin. This event takes place at 4:00 PM on Friday, prior to the opening of the EXPO Hall. 

    EXPO Hall Opens and Opening Reception  

    The EXPO Hall opens at 6:00 PM on Friday, with the opening reception lasting until 7:30 PM. SCRS has taken many safety precautions in the wake of COVID-19, such as a larger Exhibitor Hall, timed entry and fewer exhibitor booths for wider aisles and more spacing. Here is the latest safety announcement from the SCRS team.  

    Devana Solutions will be located at booth 512 and is excited to announce a few different events within our booth. 

    On-Site Demo and $250 Amazon Gift Card Drawing Opportunity  

    We welcome you to join us for a live demo of the Devana Solutions platform, which unlocks complete visibility into your clinical trials and helps to make more informed business decisions. We will be holding a drawing for eligible attendees who participate in an on-site demo. One lucky winner will be randomly drawn for a chance to win a $250 Amazon gift card. 

    Are You on Target with Your Clinical Trial Business Development?  

    Making business decisions is easy when your data is targeted. Devana Solutions is the complete solution for clinical trials industry leaders who rely upon opportunities secured, as well as opportunities missed.  

    Are you taking aim at the right targets? Let’s find out!  

    Join us at Booth 512 to test your aim.  If you can hit the bullseye, you will receive a $5 Starbucks gift card. 

    Meet Devana the Huntress  

    In Slavic mythology, our namesake, Devana, translates to the Goddess of the Hunt, a fitting moniker since the Devana Solutions platform helps your business track clinical trial data from a high-level and focus on your target. 

    Devana, the huntress herself, will be attending the Opening Reception on Friday. Devana is a rebel with a love of freedom and an obsession for the hunt. We channel her rebellious nature with our disruptive technology. We invite you to stop by booth 512 for a chance to meet Devana and snag a photo with her for your social accounts. We could use a little light-hearted fun while discussing the serious nature of our business, after all.  

    On Saturday, October 2, there will be additional registration opportunities for the Summit, a breakfast, and another SCRS welcome before a day full of events.  

    The first we are excited about is Breakout Session I, What We Really Want: Site & Patient Input for Vendors with Respect to Technology, taking place at 1:30 PM.  

    What We Really Want: Site & Patient Input for Vendors with Respect to Technology  

    This will be a great session, as it’s focused on where technology will take the clinical trials industry.  Sites and patients will share their hopes and expectations for technology providers in the clinical research space. Similar to a focus group, this Breakout Session will collaboratively collect perspectives from the field to help impress future technology adoption and advancement.  

    Devana Solutions CEO and Co-Founder, Barry Lake  will serve as one of the panelists, alongside Mary Costello, Head of Site & Investigator Network, Medable, Inc.  

    The event will be facilitated by Doug Schantz, VP, Clinical Operations, Alexion Pharmaceuticals

    Trust-Building: Utilizing Your Data to Validate Your Site  

    Breakout Session II Trust-Building: Utilizing Your Data to Validate Your Site, another event we are eagerly anticipating, takes place at 3:00 PM.  

    Devana Solutions CEO and Co-Founder, Barry Lake will facilitate the panel.  

    With sponsors and CROs seeking increased visibility into sites’ potential patient access, gone are the days when studies were awarded based on site feasibility forms or site selection visits alone. This session will help you understand the data sources that sponsors and CROs are using to further validate your site and provide perspective on what kinds of data you should track and share to position your site for selection.  

    Barry will be joined by Kerry Gorman, Director, Strategic Site Solutions, IQVIA and   

    Jeff Stein, President, Stamford Therapeutics Consortium.  

    As a 2021 Site Solutions Summit Premiere and Experience Sponsor, the entire Devana Solutions team is excited to see you at the SCRS Global Site Summit in Hollywood, Florida.     

    If you’d like to schedule an on-site demo with our team (and enter for a chance to win a $250 Amazon gift card), fill out your information below, and the Devana Solutions team will reach out to you prior to the Summit.  

    Have a question?  Ask it here too!  We love talking about data and processes to increase clinical trial efficiency and help make more informed business decisions. 

      Partner Spotlight | FOMAT Medical Research

      Chapel Hill, NC (September 3, 2021) – Devana Solutions, LLC is pleased to announce their newest client-partnership with FOMAT Medical Research, an Integrated Research Organization and partner of the esteemed hyperCORE International, focused on drug, device, and vaccine development. With over ten years of multi-therapeutic clinical trial experience in Phases I-IV, FOMAT relies on a highly experienced clinical research team with the professional expertise needed to assist Sponsors and CROs in reaching their project goals quickly and effectively. To gain further support, FOMAT made the wise decision to implement Devana Solutions’ innovative IGNITE platform.

      FOMAT’s mission is to diversify clinical trials throughout the United States & Latin America while innovating healthcare for underrepresented populations. Collaborations with health and urgent care centers, local churches, consulates, community events & centers- in addition to their internal EMR- provides access to over 100,000 patients. It ensures that Good Clinical Practice standards and ethics are upheld and understand that high-quality data is critical to the scientific community to offer improved treatments. Since implementing the Devana IGNITE platform, FOMAT is now armed with the data necessary to push its mission forward.

      FOMAT ensures speedy yet compliant project execution for its Sponsor and CRO partners, with a goal of 48 hours to complete feasibility, site selection, and respond to contract, budget, and regulatory. By utilizing the intuitive Devana IGNITE platform, FOMAT can set internal performance goals and easily track its turnaround time metrics for all clinical trial stages. One such metric that FOMAT boasts is a 6-day turnaround time from award to First Patient In (FPI). Quite an accomplishment! These metrics are beneficial for FOMAT to gauge its internal performance and increase its predictability and reliability for its Sponsor and CRO partners.

      “Very few of the leading independent research site organizations have not embraced the Devana Solutions platform for clinical trial process and performance transparency. Recently, that list got even shorter with FOMAT Medical Research becoming a Devana partner-client, joining the rest of the hyperCORE International leading site organizations to embrace the Devana Solutions’ innovative analytics and workflow automation platform,” said Devana Solutions, CEO, Barry Lake.

      Devana Solutions is proud to partner with the very driven integrated research organization, FOMAT Medical Research, to help increase clinical trial efficiency and ultimately get treatments to patients faster.

      ABOUT FOMAT MEDICAL RESEARCH:

      FOMAT Medical Research, headquartered in Oxnard, California, is an Integrated Research Organization (IRO), a subset of a Site Management Organization (SMO), focused on innovating healthcare with our high-quality services. With over 10 years of experience in participating in Phase 1 through Phase 4 clinical trials in a wide variety of therapeutic areas, we rely on a highly experienced clinical research team with the professional expertise necessary to assist Sponsors and Contract Research Organizations (CRO) with reaching their project goals quickly and effectively.

      Our sites are pre-qualified to ensure their performance will exceed expectations as quickly and effectively as possible. As soon as they enter our network, our sites abide by internationally recognized Good Clinical Practices (GCP) to ensure clinical trials are conducted ethically and effectively. At FOMAT Medical Research, we facilitate every stage of the clinical trial process and provide high-quality services and solutions for sponsors, CROs, and sites. To learn more, visit https://fomatmedical.com/.

      ABOUT hyperCORE INTERNATIONAL:

      FOMAT Medical Research is one of the founding partners of hyperCORE International’s alliance.

      Formed in 2019, hyperCORE International is a super network of highly experienced and awarded clinical research site/network companies. hyperCORE International is committed to the highest standard of research excellence with subject safety, data integrity, rapid study startup, competitive enrollment, and outstanding subject retention as top priorities. Its members have won numerous awards for performance, quality, and innovation. To learn more, visit https://hypercoreinternational.com/.

      ABOUT DEVANA SOLUTIONS LLC:

      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

      Partner Spotlight | SIGAL SMS

      Chapel Hill, NC (June 23, 2021) – Devana Solutions, LLC is pleased to announce their newest client partnership with SIGAL Site Management and Support (SIGAL SMS). Founded in 2014, SIGAL SMS began a mission to support traditional private practices in their clinical research execution strategies throughout Germany. Today, the SIGAL SMS network connects over 25 sites across Germany, with an average experience of 55 multi-therapeutic studies and 21 years per site.

      Realizing the challenges investigators and study teams face, SIGAL SMS offers extensive knowledge to help sites execute studies at the highest level. They offer complete project management support from study start-up to close-out, acting as a liaison between sites, sponsors and CROs. With their modernized approach, SIGAL SMS provides sponsors and CROs the confidence that studies are conducted in a quality and timely manner.

      With a goal to standardize their modern approach in clinical trial conduct, SIGAL SMS needed a platform to help fill the technological gaps in their site and study oversight. Now, by leveraging the Devana IGNITE platform, SIGAL SMS has the ability to automate and centrally manage the processes at each site location to ensure that their studies are successful. With a high-level view into their organizational performance via IGNITE’s robust analytics dashboards, SIGAL SMS can assist sponsors and CROs with accurate site selection. From a single source, sponsors and CROs can obtain a group of professionally set up and qualified sites, with proof of their extensive experience in conducting studies and a high patient potential.

      “The clinical trials industry has always been globally focused on advancing therapies to improve the human condition. The recent addition of SIGAL SMS, Germany’s leading research site management organization, onto the Devana Solutions’ platform is a testament to the global reach of the industry and our data analytics and workflow automation technology,” said Barry Lake, CEO & Co-Founder, Devana Solutions, LLC.

      SIGAL SMS continues their mission to expand its investigative footprint throughout Germany and set a standard in clinical research at an international level. Devana Solutions is proud to support the SIGAL SMS team and their sites to efficiently carry out studies and advance medicine globally.

      ABOUT SIGAL SMS:

      SIGAL SMS (SIGAL Site Management & Support) is a Site Management Organization (SMO), which specializes in supporting the development, establishment and optimization of established physicians and outpatient practices nationwide in Germany, on their way to become a professional study site.
      With their extensive experience in the field of clinical drug research, they know about the problems and difficulties faced by investigators and study teams as well as contractors – sponsors and CROs – every day in clinical trials. Based on this, they developed a concept and founded SIGAL SMS in 2014 to master these challenges as a reliable and competent partner. To learn more visit https://www.sigal-sms.de/en/.

      ABOUT DEVANA SOLUTIONS LLC:
      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

      Partner Spotlight | MOORE Clinical Research

      Chapel Hill, NC (May 12, 2021)- Devana Solutions, LLC is pleased to announce their newest client-partnership with MOORE Clinical Research, a privately owned and operated multi-specialty research site specializing in Phase II-IV clinical trials. Founded in 2006, MOORE has completed over 500 clinical trials across their vast and diverse patient population at their three locations in the Tampa Bay area of Florida. Through years of experience and success, MOORE continues to innovate and improve their processes to adapt to the ever-changing clinical trials landscape.

      MOORE’s forward-thinking leadership began looking into new technologies to help improve efficiencies around trial identification and management. Already armed with the RealTime CTMS platform, MOORE was introduced to Devana Solutions since the two tech companies have a seamless API-integration. Now, with the two platforms in place, MOORE is able to track trial opportunities from pre-award through trial completion, resulting in an abundance of reportable performance metrics to share with Sponsors and CROs.

      “Moore Clinical Research is an excellent addition to our Devana Solutions’ client-partner, hyperCORE International. Moore and the entire hyperCORE super network, which is now over 100 sites worldwide, are able to leverage our Devana IGNITE & PROPEL platforms to rapidly mobilize in study startup and to mine robust analytics and reporting to ensure the organization remains one of the most predictable and reliable performers in the clinical trials industry,” said Barry Lake, CEO, and Co-Founder of Devana Solutions, LLC.

      By leveraging Devana’s pioneering platforms, MOORE hopes to continue to increase their trial volume by expanding their capabilities into more therapeutic areas. After implementing Devana’s IGNITE platform, MOORE has already doubled their total number of feasibility requests and site qualification visits per month. With this increase, MOORE is well on their way to exceeding the goals set in place for 2021. Devana Solutions is looking forward to being a part of MOORE’s continued growth and success!

      ABOUT MOORE CLINICAL RESEARCH

      Founded in 2006, MOORE Clinical Research, Inc. is a privately owned and operated clinical trial site specializing and experienced in conducting multi-specialty Phase II-IV clinical trials. We have three site locations across the Tampa Bay area, each covering a large and diverse patient base.

      Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity, and reliability. Since our inception in 2006, our demonstrated track record puts MOORE Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.

      To learn more, please visit https://mooreclinicalresearch.com.

      ABOUT DEVANA SOLUTIONS LLC:

      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for sharing performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.

      Partner Spotlight | Icon Group

      CHAPEL HILL, NC (April 14, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with the Icon Group, Australia’s largest dedicated provider of private cancer care. Icon Group has an extensive clinical trials program, and through its continuing growth, Devana’s IGNITE platform will help support their ongoing success.

      Icon Research provides patients and clinicians with access to new and emerging advances in cancer treatment, conducting trials in hematology, medical oncology, and radiation oncology across a wide range of cancer types. Within the private setting, Icon Research has an unparalleled track record of participating in national and international clinical trials, including Phase I to IV, pharmaceutical industry-sponsored, and collaborative studies undertaken in partnership with various universities and collaborative groups.

      Alongside the extensive clinical trials program, Icon Research conducts in-house clinical studies across clinical hematology, medical oncology, radiation oncology, nursing, pharmacy, and medical physics. This research provides professional development opportunities to Icon investigators and the wider Icon team and continues to pave the way for new advances in quality cancer care.

      In 2020, Icon Research initiated an internal restructure to better support their expected growth, which led them to Devana Solutions. Devana’s IGNITE platform will help increase the ease and efficiency in research feasibility and start-up processes. This platform allows pre-CTMS data collection to occur, standardized reporting, pipeline tracking, and automated workflows, all of which reduce the time it takes for a trial to begin. IGNITE integrates with Icon’s preferred CTMS, RealTime, allowing a seamless transfer of a trial from feasibility and start-up assessment into an active and financially tracked clinical trial. This integration removes the need for duplicate data entry and prevents the loss of important assessment data previously collected.

      Devana Solutions supports some of the leading cancer research organizations worldwide, and the Icon Group is no exception. Their tireless dedication to combatting such an invasive and devastating disease is evident in all they do. Devana is honored to help support their efforts in advancing cancer therapies through their innovative and intuitive platforms.

      ABOUT ICON GROUP:

      Icon Group is Australia’s largest dedicated private provider of cancer care with a growing reach into Asia and New Zealand. The Group is built on a strong but simple vision to deliver the best care possible to as many people as possible, as close to home as possible.

      Icon Group’s integrated, end-to-end service model leverages the strengths of a diverse, multi-disciplinary team to achieve this mission. Their businesses encompass all aspects of quality cancer care, including treatment delivery, pharmacy, and chemotherapy compounding. To learn more, visit https://icongroup.global.

      ABOUT DEVANA SOLUTIONS LLC:

      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.

      Partner Spotlight | Indiana Clinical Trials Center

      CHAPEL HILL, NC (February 19, 2021) — Devana Solutions, LLC is proud to announce their newest client-partnership with Indiana Clinical Trials Center (ICTC). The collaboration of Devana’s IGNITE platform and the highly experienced independent research site will allow ICTC to effectively expand their investigative footprint across a growing number of Dermatology practices.

      The Indiana Clinical Trials Center was founded in 2005 by Dr. Scott Guenthner, who has conducted over 180 Phase I-IV Dermatology studies. The organization is continuing to grow and their parent company, Summit Dermatology, plans to open more sites in the Midwest over the next few years. The Indiana Clinical Trials Center’s Plainfield location will remain the central core for all new clinical trials.

      During this exciting growth period, ICTC’s use of the Devana IGNITE platform will be a vehicle to efficiently manage their trial pipeline and startup for their current and future site locations. ICTC’s central coordinating team will have real-time transparency into each site’s trial activities and performance metrics, with the ability to share accurate data with Sponsors and CROs, helping to boost their predictability and reliability. “In order to stay on target with their growth strategy, ICTC needs to grow Sponsor and CRO confidence in their ability to not only meet enrollment goals, but to rapidly get a trial up and running,” said Emily Wike, Devana’s Director of Strategic Partnerships. “Devana’s robust metrics capture and reporting will be the source of truth for ICTC and will be extremely valuable to their Sponsor and CRO partners.”

      ICTC, equipped with forward-thinking leadership, a highly experienced clinical team and now, Devana’s IGNITE platform, will help to catapult them to the next level. There is no doubt that ICTC is on the path to much success and Devana Solutions is delighted to be along their side for this journey.

      ABOUT INDIANA CLINICAL TRIALS CENTER:

      The Indiana Clinical Trials Center (ICTC) is a comprehensive and highly experienced clinical research site focusing primarily on Phase I – IV dermatologic clinical trials. ICTC is a successful extension of The Dermatology Center of Indiana (DCI) located in Plainfield, Indiana. To learn more visit https://dermindy.com/ictc-2.

      ABOUT DEVANA SOLUTIONS LLC:

      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

      Partner Spotlight | Optimed Research

      CHAPEL HILL, NC (February 18, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with Optimed Research, a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials. Optimed Research’s main site in Columbus, Ohio, is the central hub where they run over thirty trials under the direction of Owner and Founder Dr. Donald McNeil.

      Through the Integrated Research Organization model, Optimed Research partners with independent sites in their network. With a comprehensive Clinical Research Coordinator (CRC) training program, Optimed can take a CRC with little to no experience to running a trial independently. Optimed oversees business development, regulatory, data management, and financial support for each of the independent sites, allowing the Investigator and clinical staff to focus on the trial participants and meeting enrollment goals. This process helps to spread clinical trial awareness on a much broader scope.

      Due to the vast amount of oversight that Optimed provides to their sites, their VP & Director of Clinical Operations, Annie Schertzer, set out to find a solution to help manage their workload. Annie and other Optimed staff knew it was time to ditch the static spreadsheets to continue with their trending growth. With the addition of the Devana Solutions IGNITE platform, Optimed Research has a more efficient way to manage all of their independent sites within one cloud-based platform, from initial trial lead through trial completion, since Devana integrates with their CTMS, Clinical Research IO. “Optimed Research was already on the cutting-edge of clinical research with their IRO model and CRC training program, but now armed with the IGNITE platform, there are no limitations to what this group can do,” said Devana’s Director of Strategic Partnerships, Emily Wike. “I am excited to see what the future holds for Optimed!”

      Devana Solutions is pleased to stand alongside Optimed Research as they continue to grow their network of sites, proving that clinical research can be accessible to all!

      About Optimed Research

      Optimed Research is proud to be a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials.  Optimed – Columbus houses our team of experts who support all of the sites in our network.  Please visit www.optimedresearch.com for more information.

      About Devana Solutions

      Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.

      Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.

      1 2 3 4 5